Lysophosphatidic acid receptor 5 (LPAR5) Antibody (Biotin)

Este producto es parte de LPAR - Lysophosphatidic Acid Receptor
Product Graph
260€ (50 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Lysophosphatidic acid receptor 5 (LPAR5) Antibody (Biotin)
category
Primary Antibodies
provider
Abbexa
reference
abx343772
tested applications
ELISA

Description

Lysophosphatidic acid receptor 5 (LPAR5) Antibody (Biotin) is a Rabbit Polyclonal antibody conjugated to Biotin for the detection of Human LPAR5.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Lysophosphatidic acid receptor 5 (LPAR5)
Host
Rabbit
Reactivity
Human
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Biotin
Isotype
IgG
Purification
Purified by antigen affinity chromatography.
Size 1
50 µl
Size 2
100 µl
Size 3
200 µl
Size 4
1 ml
Form
Liquid
Tested Applications
ELISA
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q9H1C0
Gene ID
57121
Alias
LPAR5,GPR92,GPR93,KPG_010,LPA5,G protein-coupled receptor 92
Background
Antibody anti-LPAR5
Status
RUO

Descripción

LPAR5 is a G protein-coupled receptor activated by lysophosphatidic acid (LPA), primarily coupling to G12/13 and Gq proteins. It is expressed in the gastrointestinal tract, immune cells, and sensory neurons, where it regulates cellular responses such as migration, cytoskeletal reorganization, and inflammatory signaling. LPAR5 plays a significant role in immune modulation and inflammatory responses by mediating immune cell trafficking and cytokine release. In the gastrointestinal tract, LPAR5 regulates intestinal epithelial cell homeostasis and motility, making it relevant in gut inflammation and tissue repair. Additionally, LPAR5 is implicated in neuropathic pain, where its activation sensitizes sensory neurons, contributing to pain perception. Dysregulation of LPAR5 signaling has been linked to inflammatory diseases, neuropathic pain, and cancer progression, where it enhances tumor cell migration and survival. LPAR5 antagonists are under investigation for therapeutic use in conditions such as inflammatory bowel disease, neuropathic pain, and cancer metastasis, highlighting its potential as a target for immune and inflammatory regulation.

Related Products

abx324948

Lysophosphatidic Acid Receptor 5 (LPAR5) Antibody

LPAR5 Antibody is a Rabbit Polyclonal against LPAR5.

Ver Producto
abx339781

Lysophosphatidic Acid Receptor 5 (LPAR5) Antibody

LPAR5 Antibody is a Rabbit Polyclonal against LPAR5.

Ver Producto
abx343769

Lysophosphatidic acid receptor 5 (LPAR5) Antibody

Lysophosphatidic acid receptor 5 (LPAR5) Antibody is a Rabbit Polyclonal antibody for the detection of Human LPAR5.

Ver Producto